Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP917936.RAb17TFt9MwJUdT58581hXMeQMTe1xcX5DDT1zWXb_8OE130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917936.RAb17TFt9MwJUdT58581hXMeQMTe1xcX5DDT1zWXb_8OE130_provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP421454.RAcAXNQKnU7tSWfzC7U32hnLlp8LG1BhymfCiJ6zFoUmE130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421454.RAcAXNQKnU7tSWfzC7U32hnLlp8LG1BhymfCiJ6zFoUmE130_provenance.
• NP582753.RAVFrJV5uexyGvwSVMbJk5E7Kh88BRbURTvN07VETHhmk130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582753.RAVFrJV5uexyGvwSVMbJk5E7Kh88BRbURTvN07VETHhmk130_provenance.
• NP363563.RAayV4eZ7VYarsf3XzXMeiB8--_SIZxbQg0_ucTdxQecE130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363563.RAayV4eZ7VYarsf3XzXMeiB8--_SIZxbQg0_ucTdxQecE130_provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP363602.RAliPUnIy-uvSrSUMvqPlB-7Yxa7IUH2skmHMOywcKur4130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363602.RAliPUnIy-uvSrSUMvqPlB-7Yxa7IUH2skmHMOywcKur4130_provenance.
• NP692524.RAQZVzFKwfXiFXOI7PGqb7kwhe9BAhqqwPcrhPlH5GF4s130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692524.RAQZVzFKwfXiFXOI7PGqb7kwhe9BAhqqwPcrhPlH5GF4s130_provenance.
• NP692525.RAfJg_8tTJ0drOYagqkl7dgKdu3TW3IBEBY8_GeT7GAkw130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692525.RAfJg_8tTJ0drOYagqkl7dgKdu3TW3IBEBY8_GeT7GAkw130_provenance.
• NP692516.RAueyU3VLRdHy6I2hPaDxDXC07-yTmvJzEiGD2xmuYwWQ130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692516.RAueyU3VLRdHy6I2hPaDxDXC07-yTmvJzEiGD2xmuYwWQ130_provenance.
• NP582542.RANiGYnEu_T13JdqCxr9s7sI7HZEn57tFNakbGYOk-D3c130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582542.RANiGYnEu_T13JdqCxr9s7sI7HZEn57tFNakbGYOk-D3c130_provenance.
• NP582677.RAPSOOF57WRM-0hfn29JZErVkGTtD29ZIl-2wdLdfjxB0130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582677.RAPSOOF57WRM-0hfn29JZErVkGTtD29ZIl-2wdLdfjxB0130_provenance.
• NP363554.RAyaJwqtqpLwBzWWHpyXc4p1KIDHRDJNDDrXiGU3an4fc130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363554.RAyaJwqtqpLwBzWWHpyXc4p1KIDHRDJNDDrXiGU3an4fc130_provenance.
• NP551571.RAJ6x50IwpFEyyKUXOJ0U2oIlNfUcEvsaPcNaRL3E0P7k130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551571.RAJ6x50IwpFEyyKUXOJ0U2oIlNfUcEvsaPcNaRL3E0P7k130_provenance.
• NP692515.RAFOMSkEPNHtbnjHW84EVCjzr4_lMib28ORiTOjIT_6hw130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692515.RAFOMSkEPNHtbnjHW84EVCjzr4_lMib28ORiTOjIT_6hw130_provenance.
• NP692521.RAKnn8k-y2NFdraNnJOqzr2nTc_r8CNlLzHD3-HPm0t0M130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692521.RAKnn8k-y2NFdraNnJOqzr2nTc_r8CNlLzHD3-HPm0t0M130_provenance.
• NP692520.RA5-7Q6IyUlkuxRdq5aOUzcVthtbyj6ENII3ByiN8z1fA130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692520.RA5-7Q6IyUlkuxRdq5aOUzcVthtbyj6ENII3ByiN8z1fA130_provenance.
• NP692522.RA-ii7jc1VdiZJNBZGeiXVVK3KkU5awkDCbLb_qLdg1HM130_assertion description "[Our results demonstrated that some copy number changes thought to belong to early (MDM4 gain) or late stage (MYCN and E2F3 gain) of retinoblastoma are already present in retinoma at the same (for MDM4) or at lower (for MYCN and E2F3) copy number variation respect to retinoblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692522.RA-ii7jc1VdiZJNBZGeiXVVK3KkU5awkDCbLb_qLdg1HM130_provenance.